Health Condition 1: null- 50 patients of COPD, 50 patients of metastatic lung cancer, 50 patients of non-metastatic lung cancer, and 50 healthy volunteers
Conditions
Interventions
None listed
Sponsors
Dr BN Pandey
Eligibility
Inclusion criteria
Inclusion criteria: 1) Healthy donors: a. Age >= 50 b. Both males and females c. No known exposure to chemical/ drug exposure 2) COPD Patients: a. Age >= 50 with a history of smoking b. Both males and females c. Clinically confirmed COPD d. Willing to participate in the study 3) Lung Cancer Patients: a. Age >= 18 years b. Both males and females c. Clinically confirmed lung cancer d. Willing to participate in the study
Exclusion criteria
Exclusion criteria: 1) Healthy donors: a. Age b. Individuals with a history of lung disorder. c. Individuals with inflammatory conditions or infection during past two months 2) COPD Patients: a. Age b. Patients currently/past one week on oral or injectable corticosteroids c. Patients with other co-morbid conditions 3) Lung Cancer Patients: a. Patients with other co-morbid conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i) Cytokine levels in healthy population/COPD/metastatic lung cancer/non metastatic lung cancer and their comparisons. ii) Association between cytokine levels and clinical outcomes in lung cancer patients (metastatic and non-metastatic)Timepoint: At enrollment and every six months (after that) for COPD patients; at enrollment and 3 year follow up for lung cancer patients; at enrollment for health volunteers | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between cytokine levels and clinical outcomes in lung cancer patients (metastatic and non-metastatic)Timepoint: At 3 year follow-up after enrolment | — |
Countries
India
Contacts
Public ContactDr Shashikiran Umakanth
Melaka Manipal Medical College, MAHE
Outcome results
None listed